Clinical Trials Browser

Phase 1/2 × mogamulizumab × Other solid neoplasm × Clear all

NCT02281409 2021-04-23

Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors

Phase 1/2 Completed

17 enrolled 13 charts

Other solid neoplasm

Advanced Solid Tumors